UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:April 28, 2023
Form:S-3
CIK:0001556263
Company Name:Syros Pharmaceuticals, Inc.
File Number:333-271160